Medical News

RSS

Vespa USA supports breast cancer awareness programs

The next time you see a distinctively pink Vespa zooming by, it might just be one of the Vespa LX 50 scooters that over a dozen non-profit agencies devoted to battling breast cancer are adding to their autumn Breast Cancer Awareness initiatives.

10 Sep 2009

Machine-based lip-reading system performance compared with human lip-readers

A new study by the University of East Anglia (UEA) suggests computers are now better at lip-reading than humans.

10 Sep 2009

Galapagos starts new clinical trial for GLPG0259

Galapagos NV (Euronext: GLPG) announced today that it has initiated a second Phase I clinical trial for GLPG0259, a novel candidate drug being developed for rheumatoid arthritis (RA).

10 Sep 2009

Researchers find link between traffic noise and increased blood pressure

Traffic noise raises blood pressure. Researchers writing in BioMed Central's open access journal Environmental Health have found that people exposed to high levels of noise from nearby roads are more likely to report suffering from hypertension.

10 Sep 2009

Harkin to take the helm of Senate health committee

"Senate Majority Leader Harry Reid says that Sen. Tom Harkin — a progressive liberal and ardent supporter of President Barack Obama's plan to create a public insurance plan — will take over the health and education committee."

10 Sep 2009

Roche Group and ImmunoCellular Therapeutics sign research agreement regarding ICT-69 antibody

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.

10 Sep 2009

Oral GLP-1 Analog approved for human clinical trial

Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.

10 Sep 2009

Lead exposure may result in cardiovascular mortality

Growing evidence shows that exposure to lead in the environment is associated with cardiovascular disease, including increased risk of hypertension. However, those studies have looked at lead concentrations in blood, not bone lead, a better indicator of cumulative lead exposure over time.

10 Sep 2009

Risk of NAFLD lowers with routine physical activities

Researchers from the University of Sydney, Australia determined that patients with a sedentary lifestyle who engage in routine physical activities lower their risk of nonalcoholic fatty liver disease (NAFLD).

10 Sep 2009

Dodd rejects HELP chairmanship, skeptical Dems sound off on reform

The Washington Post: "Sen. Christopher Dodd (D-Conn.) has decided against succeeding his close friend and mentor, the late Edward M. Kennedy (D-Mass.) as chairman of the Senate's health committee, a senior Senate aide said Tuesday night. ... Dodd's decision leaves the chairmanship of the Health, Education, Labor and Pensions Committee to Sen. Tom Harkin (D-Iowa), who follows Dodd in seniority. Multiple sources in the Harkin orbit, requesting anonymity to discuss internal deliberations, said that he is certain to take over the HELP committee" (Kane, 8/8).

10 Sep 2009

New study highlights the competitive nature of drug development

Marketing exclusivity periods for first-in-class drugs have fallen dramatically in recent decades -- from a median of 10.2 years in the 1970s to 2.5 years in the early part of this decade -- underscoring the competitive nature of drug development, a new study recently completed by the Tufts Center for the Study of Drug Development has found.

10 Sep 2009

Oral and throat cancers linked to human papilloma virus

Infection by the human papilloma virus (HPV), the most common sexually transmitted disease, has been linked to more than one third of all oral and throat cancers according to Dr. Solomon Hamburg, president of the prestigious Tower Cancer Research Foundation.

10 Sep 2009

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

In 2008, the global anti-aging skincare market approached $15 billion, with 32 percent of U.S. facial skincare product launches boasting anti-aging claims many over-the-counter products are claiming to achieve comparable benefits as prescription anti-aging treatments.

10 Sep 2009

OSI Systems signs partnership agreement with Irish software firm, dabl

OSI Systems, Inc. (NASDAQ:OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has entered into an agreement with Irish software firm, dabl® Ltd.

10 Sep 2009

GlaxoSmithKline's CERVARIX receives favorable recommendation from FDA Advisory Committee

GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that clinical data support both the efficacy and safety of CERVARIX((R)), the company's candidate cervical cancer vaccine (12-1 and 11-1, respectively).

10 Sep 2009

80 percent residents aware of family building options: RESOLVE survey

According to a recent survey conducted by RESOLVE: The National Infertility Association (RESOLVE), Washington, D.C. metro-area residents are highly aware of various family building options due to a patient’s infertility diagnosis, such as medical treatment, adoption and surrogacy.

10 Sep 2009

SCAN Health Plan receives regulatory approval to expand in Northern California

SCAN Health Plan announced today that it has received regulatory approval to expand its Medicare Advantage Plan into San Francisco, Contra Costa and Santa Clara counties, effective January 1, 2010. This is the first entry into Northern California for the not-for-profit plan, which currently serves more than 110,000 Medicare members in California and Arizona.

10 Sep 2009

Nasdaq Stock Market issues delisting notice to Metabasis Therapeutics

Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the “Staff”) notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff’s delisting determination, trading of the Company’s common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.

10 Sep 2009

South East Asian health ministers adopt declaration to improve disaster preparedness, address childhood diarrhea

Health ministers from 11 member states in the WHO's South East Asian region on Tuesday at the 62nd session of the WHO Regional Committee for South East Asia adopted the Kathmandu Declaration on Protecting Health Facilities from Disasters, which commits them to make health facilities better prepared for health emergencies, Republica reports.

10 Sep 2009

Newly formed Med-Vet-Net Association to be launched

To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.

10 Sep 2009